BACKGROUND: This study evaluates the efficacy of lingual tonsil resection by transoral robotic surgery (TORS) in a large group of patients with recurrent lingual tonsillitis (RLT). METHODS: Eighty-four patients with RLT treated with a lingual tonsil surgical resection using TORS were analyzed in terms of their postoperative results, disease recurrence, postoperative dysphagia, and quality of life. RESULTS: A reduction of the mean number/year of acute lingual tonsillitis (LT) episodes emerged after surgery (5.17 vs 0.54 events), comparing the mean number of preoperative and postoperative LT episodes, a statistical significance emerged (P = .0001). The postoperative endoscopic evaluation showed 94.1% of patients with absent or poor lymphatic tissue on the tongue base. Evaluation of postoperative dysphagia showed good results with an average score of 85.9 ± 7.5. CONCLUSION: This article explains how in patients with chronic LT with medical therapy failure and impaired quality of life, TORS could represent a valid therapeutic option.
BACKGROUND: This study evaluates the efficacy of lingual tonsil resection by transoral robotic surgery (TORS) in a large group of patients with recurrent lingual tonsillitis (RLT). METHODS: Eighty-four patients with RLT treated with a lingual tonsil surgical resection using TORS were analyzed in terms of their postoperative results, disease recurrence, postoperative dysphagia, and quality of life. RESULTS: A reduction of the mean number/year of acute lingual tonsillitis (LT) episodes emerged after surgery (5.17 vs 0.54 events), comparing the mean number of preoperative and postoperative LT episodes, a statistical significance emerged (P = .0001). The postoperative endoscopic evaluation showed 94.1% of patients with absent or poor lymphatic tissue on the tongue base. Evaluation of postoperative dysphagia showed good results with an average score of 85.9 ± 7.5. CONCLUSION: This article explains how in patients with chronic LT with medical therapy failure and impaired quality of life, TORS could represent a valid therapeutic option.
Authors: Antonino Maniaci; Milena Di Luca; Jerome René Lechien; Giannicola Iannella; Calogero Grillo; Caterina Maria Grillo; Federico Merlino; Christian Calvo-Henriquez; Andrea De Vito; Giuseppe Magliulo; Annalisa Pace; Claudio Vicini; Salvatore Cocuzza; Vittoria Bannò; Isabella Pollicina; Giovanna Stilo; Alberto Bianchi; Ignazio La Mantia Journal: Sleep Breath Date: 2022-01-03 Impact factor: 2.816
Authors: Giannicola Iannella; Giuseppe Magliulo; Cristina Anna Maria Lo Iacono; Irene Claudia Visconti; Jerome R Lechien; Tiziano Perrone; Giovanni Cammaroto; Giuseppe Meccariello; Antonino Maniaci; Salvatore Cocuzza; Milena Di Luca; Andrea De Vito; Chiara Martone; Antonella Polimeni; Antonio Greco; Marco de Vincentiis; Massimo Ralli; Annalisa Pace; Giampiero Gulotta; Stefano Pelucchi; Angelo Eplite; Claudio Vicini Journal: J Clin Med Date: 2022-04-23 Impact factor: 4.964
Authors: Giannicola Iannella; Giuseppe Magliulo; Antonio Greco; Marco de Vincentiis; Massimo Ralli; Antonino Maniaci; Annalisa Pace; Claudio Vicini Journal: Int J Environ Res Public Health Date: 2022-02-21 Impact factor: 3.390
Authors: Giulio Gasparini; Gianmarco Saponaro; Mattia Todaro; Gabriele Ciasca; Lorenzo Cigni; Piero Doneddu; Camillo Azzuni; Enrico Foresta; Paolo De Angelis; Giorgio Barbera; Roberta Gaia Parcianello; Horia Vasile Hreniuc; Alessandro Moro Journal: Int J Environ Res Public Health Date: 2021-03-01 Impact factor: 3.390